- Growth StageExpanding market presence
- Top InvestorsThis company has received a significant amount of investment from top investors
- Website
- Locations
- Company size
- 51-200 people
- Total raised
- $70.5M
- Company type
- Startup
- Markets
Lifebit careers
Lifebit is a leading innovator in bioinformatics software solutions and AI. In 2021, the London, UK based company closed its Series B funding round of US$60M led by Tiger Global, to fuel ongoing product innovations and global market expansion.
Lifebit is pushing forward the frontiers of health and knowledge by democratising access to, and powering analyses of, omics big data. We are the pioneers revolutionising bioinformatics and biomedical data analysis.
The company’s flagship product, Lifebit CloudOS, is fast becoming the industry’s standard for unified and secure research over distributed big data. On top of its core foundation, the platform provides integration to open-source analysis and visualisation tools, as well as a marketplace of proprietary ones, a powerful data and cohort browser, and advanced AI functionality that together are powering discoveries in drug discovery and vaccine development.
Top tier pharmaceutical organisations, global research institutes, and bioinformatics companies the world over are deploying Lifebit CloudOS. In April 2020 we closed our Series A funding round with tremendous support from new and previous investors. Based in London, UK, Lifebit is a diverse team spanning Europe and North America, with each person empowered and involved in every aspect of the business.
Lifebit is pushing forward the frontiers of health and knowledge by democratising access to, and powering analyses of, omics big data. We are the pioneers revolutionising bioinformatics and biomedical data analysis.
The company’s flagship product, Lifebit CloudOS, is fast becoming the industry’s standard for unified and secure research over distributed big data. On top of its core foundation, the platform provides integration to open-source analysis and visualisation tools, as well as a marketplace of proprietary ones, a powerful data and cohort browser, and advanced AI functionality that together are powering discoveries in drug discovery and vaccine development.
Top tier pharmaceutical organisations, global research institutes, and bioinformatics companies the world over are deploying Lifebit CloudOS. In April 2020 we closed our Series A funding round with tremendous support from new and previous investors. Based in London, UK, Lifebit is a diverse team spanning Europe and North America, with each person empowered and involved in every aspect of the business.
Lifebit hasn't added any jobs yet
Get notified when Lifebit posts new jobs.
Pablo Prieto Barja
Dr. Maria Chatzou
Co-founder & CEO Lifebit, PhD in Biomedicine, MSc in Bioinformatics and Machine Learning, BSc in Computer Science and Biomedical Informatics
Total raised
$70.5M
Funded over
3 rounds
Latest round
Series B (Sep 2021)
BNY • Pittsburgh • 3 days ago
Moda Operandi • Brooklyn • 2 weeks ago
Tower Research Capital • Shanghai • 2 weeks ago
Quartzy • Houston • 3 weeks ago
Penumbra • Berlin • 3 weeks ago